Zoetis Inc. (ZTS)
NYSE: ZTS · Real-Time Price · USD
175.67
+0.11 (0.06%)
Nov 20, 2024, 4:00 PM EST - Market closed
Zoetis Revenue
Zoetis had revenue of $2.39B in the quarter ending September 30, 2024, with 11.02% growth. This brings the company's revenue in the last twelve months to $9.15B, up 9.33% year-over-year. In the year 2023, Zoetis had annual revenue of $8.54B with 5.74% growth.
Revenue (ttm)
$9.15B
Revenue Growth
+9.33%
P/S Ratio
8.76
Revenue / Employee
$649,078
Employees
14,100
Market Cap
79.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.54B | 464.00M | 5.74% |
Dec 31, 2022 | 8.08B | 304.00M | 3.91% |
Dec 31, 2021 | 7.78B | 1.10B | 16.49% |
Dec 31, 2020 | 6.68B | 415.00M | 6.63% |
Dec 31, 2019 | 6.26B | 435.00M | 7.47% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CVS Health | 367.25B |
McKesson | 330.19B |
Cencora | 293.96B |
The Cigna Group | 229.75B |
Elevance Health | 174.02B |
HCA Healthcare | 69.62B |
GSK | 41.97B |
Gilead Sciences | 28.30B |
ZTS News
- 14 hours ago - Zoetis Inc. (ZTS) Management presents at Jefferies London Healthcare Conference (Transcript) - Seeking Alpha
- 1 day ago - Zoetis to Participate in the Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 3 days ago - Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy - Seeking Alpha
- 9 days ago - Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer Role - Business Wire
- 10 days ago - Zoetis Q3: Strong Osteoarthritis Pain Franchise - Seeking Alpha
- 13 days ago - Zoetis to Participate in Jefferies London Healthcare Conference - Business Wire
- 16 days ago - Zoetis Inc. (ZTS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Zoetis Inc. For Fraud - Accesswire